Dictate the Brain Cancer Space for Years, page-7

I wondered if anyone listened sent the synopsis to friends and relatives.

Sister replied "Nope, I sat and listened to it. I thought it was gonna be about an hour long but it turned out to be about half an hour or so. I didn’t know if there was any new news or if it was just reaffirming what people already had concluded.
It just sounds like the guy is confident and not over the top. It’s just that I’ve never heard anything like this before, so I don’t know how much a CEO will try to inflate or assure shareholders. And I saw that someone was talking about down the road the company being sold. That sounds like it’s way down the road to me.

My reply was
"He knows his stuff, unlike the CEO of previous iteration of the company, Novogen, whose origins sprung from veterinary medicine. The main knock I had on prev. CEO was all the unsubstantiated crap he'd throw out, sorta like Trump now that I think about it... That's why Kazia's price remained so low for years after Dr. Garner took the reins. I told company at the time of ex-CEO's departure that they needed to cut the hype, as it reduced their credibility. Evidently they realized the same thing, and Kazia has been unassuming/understated since. It's only in the last year that Garner has shown signs of enthusiasm. He still is loathe to do hyping, but has to be honest with shareholders and the public about the company's potential. I'm glad you got to hear him speak. BTW, the DIPG progression-free-survival (PFS) data of 96% at 6 months is amazing, considering overall survival (OS) is only 9 months for that disease. I think people are overlooking that stat. St. Jude's trial next step will pair Pax with ONC-21, which is the combo that Dr. Dun hit upon when in very late treatment of his daughter. The best is yet to come, though the share price will likely drop between data read-outs. Don't worry about it. Garner wants to take Pax as far as possible on his own, to get a higher valuation for it and better deal when Kazia partners. He is NOT going to sell the company, as it's now "his baby". .."